Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

GHK-Cu

Copper Tripeptide-1, Glycyl-L-Histidyl-L-Lysine Copper, Prezatide Copper

Quick Stats
Studies 149
Trials 1
Score 3
2005 pubmed

Effects of copper tripeptide on the growth and expression of growth factors by normal and irradiated fibroblasts.

Pollard. Jeffrey D JD; Quan. Susan S; Kang. Thomas T; Koch. R James RJ

Key Findings

  • GHK‑Cu (1 × 10⁻⁹ M) speeds up the division of both normal and radiation‑damaged fibroblasts in serum‑free culture.
  • Radiation‑damaged fibroblasts remain viable and can proliferate without serum, providing a useful model for testing growth‑factor production.
  • Treated irradiated fibroblasts show an early rise in basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF), both important for wound healing.

Practical Outcomes

  • For biohackers, the data supports the idea that low‑dose GHK‑Cu may help skin repair and possibly anti‑aging by promoting fibroblast growth and growth‑factor release. While the study is only in vitro, it aligns with existing anecdotal and clinical reports of topical GHK‑Cu benefits. If you choose to try it, start with established safe topical formulations (e.g., 0.1–0.5% creams) and track skin healing or texture, keeping in mind that human dosing guidelines are still limited.

Summary

A lab study found that a tiny amount of the copper peptide GHK‑Cu (about 1 nanomolar) makes skin cells called fibroblasts grow faster and release more healing proteins, even when those cells have been damaged by radiation. This suggests the peptide could boost wound repair and skin health, but the work was done only in cell dishes, not in people.

Abstract

To evaluate the effects of copper tripeptide (GHK-Cu) on the growth and autocrine production of basic fibroblast growth factor, transforming growth factor beta1, and vascular endothelial growth factor by normal and irradiated fibroblasts in a serum-free in vitro environment. Primary human dermal fibroblast cell lines were established after explantation from intraoperative specimens obtained from patients who had undergone radiation therapy for head and neck cancer. Normal and irradiated fibroblasts were propagated in serum- and growth factor-free media. Treatment groups were exposed to GHK-Cu (1 x 10(-9) mol/L). We measured cell counts and production of basic fibroblast growth factor, transforming growth factor beta1, and vascular endothelial growth factor. Irradiated fibroblasts survived and replicated in serum-free media. The population-doubling times of normal and irradiated fibroblasts exposed to GHK-Cu were faster than those of nontreated controls. Irradiated fibroblasts treated with GHK-Cu doubled at a rate that approximated that of untreated controls, and produced significantly more basic fibroblast growth factor and vascular endothelial growth factor than untreated controls early after GHK-Cu exposure. Irradiated fibroblasts survive and replicate in serum-free media, establishing this model as ideal for evaluating growth factor production in vitro. Copper tripeptide accelerates the growth of normal and irradiated fibroblasts to the point where treated irradiated fibroblasts approximate the population-doubling time of normal controls. An early increase in basic fibroblast growth factor and vascular endothelial growth factor production by GHK-Cu-treated irradiated fibroblasts may improve wound healing.

Study Information

Provider

pubmed

Year

2005

DOI

10.1001/archfaci.7.1.27